References
Thomson ABR. Gastro-oesophageal reflux in the elderly: role of drug therapy in management. Drugs Aging 2001; 18(6): 409–14
Gawrieh S, Shaker R. Medical management of nocturnal symptoms of gastro-oesophageal reflux disease in the elderly. Drugs Aging 2003; 20(7): 509–16
Zhu H, Pace F, Sangaletti O, et al. Features of symptomatic gastroesophageal reflux in elderly patients. Scand J Gastroenterol 1993; 28: 235–8
Farup C, Kleinman L, Sloan S, et al. The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life. Arch Intern Med 2001; 161(1): 45–52
Pilotto A, Franceschi M, Leandro G, et al. Long-term clinical outcome of elderly patients with reflux esophagitis: a six-month to three-year follow-up study. Am J Ther 2002; 9(4): 295–300
British National Formulary. No. 46. London: The Pharmaceutical Press, 2003 Sep
Hendel J, Hendel L, Aggestrup S. Morning or evening dosage of omeprazole for gastro-oesophageal reflux disease? Aliment Pharmacol Ther 1995; 9(6): 693–7
Hatlebakk JG, Katz PO, Kuo B, et al. Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40mg daily. Aliment Pharmacol Ther 1998; 12(12): 1235–40
Flockhart DA, Desta Z, Mahal SK. Selection of drugs to treat gastro-oesophageal reflux disease: the role of drug interactions. Clin Pharmacokinet 2000; 39(4): 295–309
Thjodleifsson B. Treatment of acid-related diseases in the elderly with emphasis on the use of proton pump inhibitors. Drugs Aging 2002; 19(12): 911–27
Orr WC, Hamish MJ. Sleep-related gastro-oesophageal reflux: provocation with a late evening meal and treatment with acid suppression. Aliment Pharmacol Ther 1998; 12(10): 1033–8
Robinson M, Rodriguez-Stanley S, Ciociola AA, et al. Control of nocturnal gastric acidity: a role for low dose bedtime ranitidine to supplement daily omeprazole. Dig Dis Sci 2002; 47(12): 265–73
Xue S, Katz PO, Banerjee P, et al. Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors. Aliment Pharmacol Ther 2001; 15(9): 1351–6
Richter JE. Gastroesophageal reflux disease in the older patient: presentation, treatment, and complications. Am J Gastroenterol 2000; 95(2): 368–73
Ramirez B, Richter JE. Promotility drugs in the treatment of gastroesophageal reflux disease. Aliment Pharmacol Ther 1993; 7: 5–20
Rights and permissions
About this article
Cite this article
Proton-pump inhibitors pivotal for nocturnal qastro-oesophaqeal reflux disease in the elderly. Drugs Ther. Perspect 20, 12–16 (2004). https://doi.org/10.2165/00042310-200420050-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200420050-00005